What is biotechnology assets?

Biotechnology Assets is a biotechnology group strategically focused on the ‘One Health’ concept which encompasses human and animal health. Subsidiaries and a global commercial structure devoted to the monetisation of their different high-valued assets.

What currency does biotechnology assets SA use?

Data as of Jan 12 2024. Currency figures normalised to Biotechnology Assets SA's reporting currency: Euro EUR Biotechnology Assets SA (BST:MCE) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.

Is the biotechnology sector worth investing in Indian stock market?

If the overall Biotechnology sector of the Indian stock market appears worth investing, then explore the list of the following stocks which rank at the top on the factors of growth (earnings-per-share EPS), value (price-earnings ratio PE), and momentum (year-to date YTD returns). The information is presented in three sections.

How big is the global biotechnology market?

Nov 04, 2022 (Heraldkeepers) -- United States, New York City: According to the research report published by Polaris Market Research, the Global Biotechnology Market Size Is Expected To Reach USD 3,088.54 Billion By 2029, at a CAGR of 15.6% during the forecast period.